[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Hospital-acquired infections (HAIs) Control Market Growth (Status and Outlook) 2022-2028

January 2022 | 88 pages | ID: G29AD6A78652EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Hospital-acquired infections (HAIs) Control will have significant change from previous year. According to our (LP Information) latest study, the global Hospital-acquired infections (HAIs) Control market size is USD million in 2022 from USD 5578.1 million in 2021, with a change of % between 2021 and 2022. The global Hospital-acquired infections (HAIs) Control market size will reach USD 6859.5 million in 2028, growing at a CAGR of 3.0% over the analysis period.

The United States Hospital-acquired infections (HAIs) Control market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hospital-acquired infections (HAIs) Control market, reaching US$ million by the year 2028. As for the Europe Hospital-acquired infections (HAIs) Control landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Hospital-acquired infections (HAIs) Control players cover STERIS Corporation, Advanced Sterilization Products Division, Hoffmann-La Roche, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Hospital-acquired infections (HAIs) Control market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
  • Diagnostic techniques
  • Dleaning and sterilization
  • Treatment
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
  • General Hospital
  • Infectious Disease Hospital
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
  • STERIS Corporation
  • Advanced Sterilization Products Division
  • Hoffmann-La Roche
  • Pfizer
  • Becton Dickinson
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Hospital-acquired infections (HAIs) Control Market Size 2017-2028
  2.1.2 Hospital-acquired infections (HAIs) Control Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Hospital-acquired infections (HAIs) Control Segment by Type
  2.2.1 Diagnostic techniques
  2.2.2 Dleaning and sterilization
  2.2.3 Treatment
2.3 Hospital-acquired infections (HAIs) Control Market Size by Type
  2.3.1 Hospital-acquired infections (HAIs) Control Market Size CAGR by Type (2017 VS 2022 VS 2028)
  2.3.2 Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
2.4 Hospital-acquired infections (HAIs) Control Segment by Application
  2.4.1 General Hospital
  2.4.2 Infectious Disease Hospital
2.5 Hospital-acquired infections (HAIs) Control Market Size by Application
  2.5.1 Hospital-acquired infections (HAIs) Control Market Size CAGR by Application (2017 VS 2022 VS 2028)
  2.5.2 Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)

3 HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL MARKET SIZE BY PLAYER

3.1 Hospital-acquired infections (HAIs) Control Market Size Market Share by Players
  3.1.1 Global Hospital-acquired infections (HAIs) Control Revenue by Players (2020-2022)
  3.1.2 Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Players (2020-2022)
3.2 Global Hospital-acquired infections (HAIs) Control Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL BY REGIONS

4.1 Hospital-acquired infections (HAIs) Control Market Size by Regions (2017-2022)
4.2 Americas Hospital-acquired infections (HAIs) Control Market Size Growth (2017-2022)
4.3 APAC Hospital-acquired infections (HAIs) Control Market Size Growth (2017-2022)
4.4 Europe Hospital-acquired infections (HAIs) Control Market Size Growth (2017-2022)
4.5 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Growth (2017-2022)

5 AMERICAS

5.1 Americas Hospital-acquired infections (HAIs) Control Market Size by Country (2017-2022)
5.2 Americas Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022)
5.3 Americas Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Hospital-acquired infections (HAIs) Control Market Size by Region (2017-2022)
6.2 APAC Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022)
6.3 APAC Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Hospital-acquired infections (HAIs) Control by Country (2017-2022)
7.2 Europe Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022)
7.3 Europe Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Hospital-acquired infections (HAIs) Control by Region (2017-2022)
8.2 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022)
8.3 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HOSPITAL-ACQUIRED INFECTIONS (HAIS) CONTROL MARKET FORECAST

10.1 Global Hospital-acquired infections (HAIs) Control Forecast by Regions (2023-2028)
  10.1.1 Global Hospital-acquired infections (HAIs) Control Forecast by Regions (2023-2028)
  10.1.2 Americas Hospital-acquired infections (HAIs) Control Forecast
  10.1.3 APAC Hospital-acquired infections (HAIs) Control Forecast
  10.1.4 Europe Hospital-acquired infections (HAIs) Control Forecast
  10.1.5 Middle East & Africa Hospital-acquired infections (HAIs) Control Forecast
10.2 Americas Hospital-acquired infections (HAIs) Control Forecast by Country (2023-2028)
  10.2.1 United States Hospital-acquired infections (HAIs) Control Market Forecast
  10.2.2 Canada Hospital-acquired infections (HAIs) Control Market Forecast
  10.2.3 Mexico Hospital-acquired infections (HAIs) Control Market Forecast
  10.2.4 Brazil Hospital-acquired infections (HAIs) Control Market Forecast
10.3 APAC Hospital-acquired infections (HAIs) Control Forecast by Region (2023-2028)
  10.3.1 China Hospital-acquired infections (HAIs) Control Market Forecast
  10.3.2 Japan Hospital-acquired infections (HAIs) Control Market Forecast
  10.3.3 Korea Hospital-acquired infections (HAIs) Control Market Forecast
  10.3.4 Southeast Asia Hospital-acquired infections (HAIs) Control Market Forecast
  10.3.5 India Hospital-acquired infections (HAIs) Control Market Forecast
  10.3.6 Australia Hospital-acquired infections (HAIs) Control Market Forecast
10.4 Europe Hospital-acquired infections (HAIs) Control Forecast by Country (2023-2028)
  10.4.1 Germany Hospital-acquired infections (HAIs) Control Market Forecast
  10.4.2 France Hospital-acquired infections (HAIs) Control Market Forecast
  10.4.3 UK Hospital-acquired infections (HAIs) Control Market Forecast
  10.4.4 Italy Hospital-acquired infections (HAIs) Control Market Forecast
  10.4.5 Russia Hospital-acquired infections (HAIs) Control Market Forecast
10.5 Middle East & Africa Hospital-acquired infections (HAIs) Control Forecast by Region (2023-2028)
  10.5.1 Egypt Hospital-acquired infections (HAIs) Control Market Forecast
  10.5.2 South Africa Hospital-acquired infections (HAIs) Control Market Forecast
  10.5.3 Israel Hospital-acquired infections (HAIs) Control Market Forecast
  10.5.4 Turkey Hospital-acquired infections (HAIs) Control Market Forecast
  10.5.5 GCC Countries Hospital-acquired infections (HAIs) Control Market Forecast
10.6 Global Hospital-acquired infections (HAIs) Control Forecast by Type (2023-2028)
10.7 Global Hospital-acquired infections (HAIs) Control Forecast by Application (2023-2028)

11 KEY PLAYERS ANALYSIS

11.1 STERIS Corporation
  11.1.1 STERIS Corporation Company Information
  11.1.2 STERIS Corporation Hospital-acquired infections (HAIs) Control Product Offered
  11.1.3 STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2020-2022)
  11.1.4 STERIS Corporation Main Business Overview
  11.1.5 STERIS Corporation Latest Developments
11.2 Advanced Sterilization Products Division
  11.2.1 Advanced Sterilization Products Division Company Information
  11.2.2 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product Offered
  11.2.3 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2020-2022)
  11.2.4 Advanced Sterilization Products Division Main Business Overview
  11.2.5 Advanced Sterilization Products Division Latest Developments
11.3 Hoffmann-La Roche
  11.3.1 Hoffmann-La Roche Company Information
  11.3.2 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product Offered
  11.3.3 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2020-2022)
  11.3.4 Hoffmann-La Roche Main Business Overview
  11.3.5 Hoffmann-La Roche Latest Developments
11.4 Pfizer
  11.4.1 Pfizer Company Information
  11.4.2 Pfizer Hospital-acquired infections (HAIs) Control Product Offered
  11.4.3 Pfizer Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2020-2022)
  11.4.4 Pfizer Main Business Overview
  11.4.5 Pfizer Latest Developments
11.5 Becton Dickinson
  11.5.1 Becton Dickinson Company Information
  11.5.2 Becton Dickinson Hospital-acquired infections (HAIs) Control Product Offered
  11.5.3 Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2020-2022)
  11.5.4 Becton Dickinson Main Business Overview
  11.5.5 Becton Dickinson Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Hospital-acquired infections (HAIs) Control Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Diagnostic techniques
Table 3. Major Players of Dleaning and sterilization
Table 4. Major Players of Treatment
Table 5. Hospital-acquired infections (HAIs) Control Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
Table 8. Hospital-acquired infections (HAIs) Control Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)
Table 11. Global Hospital-acquired infections (HAIs) Control Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Player (2020-2022)
Table 13. Hospital-acquired infections (HAIs) Control Key Players Head office and Products Offered
Table 14. Hospital-acquired infections (HAIs) Control Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hospital-acquired infections (HAIs) Control Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Regions (2017-2022)
Table 19. Americas Hospital-acquired infections (HAIs) Control Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Hospital-acquired infections (HAIs) Control Market Size Market Share by Country (2017-2022)
Table 21. Americas Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
Table 23. Americas Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)
Table 25. APAC Hospital-acquired infections (HAIs) Control Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Region (2017-2022)
Table 27. APAC Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
Table 29. APAC Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)
Table 31. Europe Hospital-acquired infections (HAIs) Control Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Country (2017-2022)
Table 33. Europe Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
Table 35. Europe Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Hospital-acquired infections (HAIs) Control
Table 44. Key Market Challenges & Risks of Hospital-acquired infections (HAIs) Control
Table 45. Key Industry Trends of Hospital-acquired infections (HAIs) Control
Table 46. Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Hospital-acquired infections (HAIs) Control Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Hospital-acquired infections (HAIs) Control Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Hospital-acquired infections (HAIs) Control Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Hospital-acquired infections (HAIs) Control Market Size Market Share Forecast by Application (2023-2028)
Table 52. STERIS Corporation Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 53. STERIS Corporation Hospital-acquired infections (HAIs) Control Product Offered
Table 54. STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. STERIS Corporation Main Business
Table 56. STERIS Corporation Latest Developments
Table 57. Advanced Sterilization Products Division Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 58. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product Offered
Table 59. Advanced Sterilization Products Division Main Business
Table 60. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Advanced Sterilization Products Division Latest Developments
Table 62. Hoffmann-La Roche Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 63. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product Offered
Table 64. Hoffmann-La Roche Main Business
Table 65. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Hoffmann-La Roche Latest Developments
Table 67. Pfizer Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 68. Pfizer Hospital-acquired infections (HAIs) Control Product Offered
Table 69. Pfizer Main Business
Table 70. Pfizer Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Pfizer Latest Developments
Table 72. Becton Dickinson Details, Company Type, Hospital-acquired infections (HAIs) Control Area Served and Its Competitors
Table 73. Becton Dickinson Hospital-acquired infections (HAIs) Control Product Offered
Table 74. Becton Dickinson Main Business
Table 75. Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Becton Dickinson Latest Developments

LIST OF FIGURES

Figure 1. Hospital-acquired infections (HAIs) Control Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hospital-acquired infections (HAIs) Control Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Type in 2021
Figure 7. Hospital-acquired infections (HAIs) Control in General Hospital
Figure 8. Global Hospital-acquired infections (HAIs) Control Market: General Hospital (2017-2022) & ($ Millions)
Figure 9. Hospital-acquired infections (HAIs) Control in Infectious Disease Hospital
Figure 10. Global Hospital-acquired infections (HAIs) Control Market: Infectious Disease Hospital (2017-2022) & ($ Millions)
Figure 11. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Application in 2021
Figure 12. Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Player in 2021
Figure 13. Global Hospital-acquired infections (HAIs) Control Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Hospital-acquired infections (HAIs) Control Market Size 2017-2022 ($ Millions)
Figure 15. APAC Hospital-acquired infections (HAIs) Control Market Size 2017-2022 ($ Millions)
Figure 16. Europe Hospital-acquired infections (HAIs) Control Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size 2017-2022 ($ Millions)
Figure 18. Americas Hospital-acquired infections (HAIs) Control Value Market Share by Country in 2021
Figure 19. Americas Hospital-acquired infections (HAIs) Control Consumption Market Share by Type in 2021
Figure 20. Americas Hospital-acquired infections (HAIs) Control Market Size Market Share by Application in 2021
Figure 21. United States Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Region in 2021
Figure 26. APAC Hospital-acquired infections (HAIs) Control Market Size Market Share by Application in 2021
Figure 27. China Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Country in 2021
Figure 34. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Type in 2021
Figure 35. Europe Hospital-acquired infections (HAIs) Control Market Size Market Share by Application in 2021
Figure 36. Germany Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Market Share by Application in 2021
Figure 44. Egypt Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Hospital-acquired infections (HAIs) Control Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 50. APAC Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 51. Europe Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 53. United States Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 54. Canada Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 57. China Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 58. Japan Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 59. Korea Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 61. India Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 62. Australia Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 63. Germany Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 64. France Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 65. UK Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 66. Italy Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 67. Russia Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 68. Spain Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 71. Israel Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Hospital-acquired infections (HAIs) Control Market Size 2023-2028 ($ Millions)


More Publications